94278 ⎘
Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms Sulfur atoms
CRYSTALLINE POLYMORPHS OF MITAPIVAT AND MITAPIVAT HEMISULFATE
#2ACETYL-COA CARBOXYLASE MODULATORS
#3NOVEL NAPHTHYL AND ISOQUINOLINE SULFONAMIDE DERIVATIVES
#4HISTONE DEACETYLASE 6 INHIBITORS AND METHOD FOR TREATING NEUROPATHIC PAIN
#5SOLID STATE FORMS OF MITAPIVAT AND PROCESS FOR PREPARATION THEREOF
#6TEAD INHIBITORS AND METHODS OF USE
#7USES OF CYCLOBUTYL DIHYDROQUINOLINE SULFONAMIDE COMPOUNDS
#8NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS
#9HALOALLYLAMINE SULFONE DERIVATIVE INHIBITORS OF LYSYL OXIDASES AND USES THEREOF
#10ANTIDEGRADANT COMPOUNDS AND USES THEREOF
#11SULFONYLUREAS AND RELATED COMPOUNDS AND USE OF SAME
#12THERAPEUTIC COMPOUNDS AND COMPOSITIONS
#13PHOSPHINE-IMINO-QUINOLINE AND RELATED LIGANDS FOR USE IN ETHYLENE OLIGOMERIZATION PROCESSES
#14QUINOLINE COMPOUND SUSTAINED-RELEASE TABLET AND PREPARATION METHOD THEREFOR
#15POLYSUBSTITUTED NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVES, PREPARATION METHOD AND USE THEREOF
#16A TRIFLUOROMETHYL THIANTHRENIUM COMPOUND, PROCESS FOR PREPARING THE SAME AND THE USE THEREOF
#17Compounds for the Treatment Of Acute and Chronic Kidney Disease
#18QUINOLINE MERCAPTOACETATE SULFONAMIDE DERIVATIVE, INTERMEDIATE, PHARMACEUTICAL DERIVATIVE OR FORMULATION, AND PREPARATION METHOD AND USE THEREFOR
#19QUINOLINE DERIVATIVES AND USES IN MANAGING CANCER
#20Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use
#21METASTASIS-INHIBITING COMPOSITION OF NOVEL METHYLSULFONAMIDE DERIVATIVE COMPOUND
#22Compounds and compositions for treating conditions associated with NLRP activity
#23COMPOSITIONS AND METHODS FOR TREATING MUSCULAR DYSTROPHIES
#24Compounds for the treatment of acute and chronic kidney disease
#25QUINOLINONE DERIVATIVES AS METHIONINE ADENOSYLTRANSFERASE 2A INHIBITORS
#26SULFONAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING MENTAL ILLNESS
#27CRYSTALLINE SALT FORMS OF N-(4-(4-(CYCLOPROPYLMETHYL)PIPERAZINE-1-CARBONYL)PHENYL)QUINOLINE-8-SULFONAMIDE
#28Methods and Compositions for Targeting Tregs using CCR8 Inhibitors
#292-amino-N-(amino-oxo-aryl-lambda-sulfanylidene)acetamide compounds and their therapeutic use
#30Solid state forms of Mitapivat and process for preparation thereof
#31Compounds and compositions for treating conditions associated with NLRP activity
#32DISUBSTITUTED ALKYNE DERIVATIVES
#33COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY
#34METHODS AND MATERIALS FOR INHIBITING NF-kB ACTIVITY
#35Sulfonamide carboxamide compounds
#36HETEROCYCLIC TRPML1 AGONISTS
#37Cyclobutyl dihydroquinoline sulfonamide compounds
#38WDR5-MYC INHIBITORS
#39HISTONE DEACETYLASE 6 INHIBITORS AND METHOD FOR TREATING NEUROPATHIC PAIN
#40DIFLUOROHALOALLYLAMINE SULFONE DERIVATIVE INHIBITORS OF LYSYL OXIDASES, METHODS OF PREPARATION, AND USES THEREOF
#41METHODS AND COMPOSITIONS FOR PREVENTION OF ANAPHYLAXIS
#42Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use
#43Compounds for the treatment of acute and chronic kidney disease
#44Sulfonylureas and related compounds and use of same
#45Haloallylamine sulfone derivative inhibitors of lysyl oxidases and uses thereof
#46QUINOLINE SULFONAMIDES USEFUL TO TREAT DISEASE
#47C-met modulators and methods of use
#48ACETYL-COA CARBOXYLASE MODULATORS
#49Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use
#50Therapeutic compounds and compositions
#51Compounds and compositions for treating conditions associated with NLRP activity
#52Methods and compositions for treatment of muscle wasting, muscle weakness, and/or cachexia
#53C-Met Modulators and Methods of Use
#54Sulfonamide carboxamide compounds
#55Aromatic compound, pharmaceutical composition and use thereof
#56Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
#57Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
#58Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
#59Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
#60SULFONAMIDE OR AMIDE COMPOUNDS, COMPOSITIONS AND METHODS FOR THE PROPHYLAXIS AND/OR TREATMENT OF AUTOIMMUNE, INFLAMMATION OR INFECTION RELATED DISORDERS
#61Imaging composition and uses thereof
#62Aromatic compound, pharmaceutical composition and use thereof
#63Substituted sulfoximine compounds
#64NOVEL ANTI-INFLAMMATORY AGENTS
#65FLUOROPHORE-BASED KINASE SENSORS
#66Imaging composition and uses thereof
#67SALICYLIC ACID DERIVATIVES, PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, COMPOSITION THEREOF AND METHOD OF USE THEREOF
#68Sulfonylureas and related compounds and use of same
#69Therapeutic compounds and compositions
#70QUINOLINE SULFONAMIDES USEFUL TO TREAT DISEASE
#71Histone deacetylase 6 inhibitors and use thereof
#72Tricyclic sulfones as RORγ modulators
#73THERAPEUTIC COMPOUNDS AND COMPOSITIONS
#74Compounds for use as an anti-bacterial or anti-fungal agent and as a zinc sensor
#75Indazole sulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamma (ROR gamma (T))
#76MDR-reversing 8-hydroxy-quinoline derivatives
#77Acetyl-CoA carboxylase modulators
#78Compounds and compositions for treating conditions associated with NLRP activity
#79Imaging composition and uses thereof
#80Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
#81Benzimidazole sulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamma (ROR gamma (T))
#82Sodium salt of uric acid transporter inhibitor and crystalline form thereof
#83Rac inhibitors
#84Process for the preparation of polyfluoroalkylated quinolines
#85Photocatalyst-free, light-induced carbon-sulfur cross-coupling methods
#86Alkynyl dihydroquinoline sulfonamide compounds
#87Quinoline compounds, preparation methods thereof, and uses thereof as urate transporter inhibitor drug
#88COMT inhibiting methods and compositions
#89Tetrahydroquinoline sulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamma (ROR gamma (t))
#90Compounds for inhibiting c-myc/max/DNA complex formation
#91Compounds for optically active devices
#92Sodium salt of uric acid transporter inhibitor and crystalline form thereof
#93Tricyclic sulfones as ROR gamma modulators
#94Sulfonylureas and related compounds and use of same
#95Compounds for inhibiting c-Myc/Max/DNA complex formation
#96Isothiocyanate compounds and isothiocyanate XPO1 protein inhibitor drugs thereof
#97N-acyl-arylsulfonamide derivatives as aminoacyl-tRNA synthetase inhibitors
#98Tricyclic sulfones as RORγ modulators
#99C-met modulators and methods of use
#100Indazole sulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamma (ROR γ (T))
#101NOVEL ANTI-INFLAMMATORY AGENTS
#102Imaging composition and uses thereof
#103QUINOLONES AS INHIBITORS OF CLASS IV BROMODOMAIN PROTEINS
#104URAT1 inhibitor
#105Salicylic acid derivatives, pharmaceutically acceptable salt thereof, composition thereof and method of use thereof
#106Therapeutic compounds and compositions
#107IDENTIFICATION OF COMPOUNDS THAT DISPERSE TDP-43 INCLUSIONS
#108Inhibitors of paxillin function and related compositions and methods
#109Tricyclic sulfones as RORγ modulators
#110Use of small molecule inhibitors targeting the interaction between RAC GTPase and p67
#111Arylquinoline and analog compounds and use thereof to treat cancer
#112COMT inhibiting methods and compositions
#113c-Met Modulators and Method of Use
#114Acetyl CoA carboxylase modulators
#115Bicyclic sulfonamide compounds as sodium channel inhibitors
#116Cycloalkyl acid derivative, preparation method thereof, and pharmaceutical application thereof
#117Bicyclic sulfonamide compounds as sodium channel inhibitors
#118Quinoline derivatives and their applications
#119Use of a Compound for Inducing Differentiation of Mesenchymal Stem Cells into Cartilage Cells
#120Quinolinone derivatives
#121Activators of human pyruvate kinase
#122Salicylic acid derivatives, pharmaceutically acceptable salt thereof, composition thereof and method of use thereof
#123Substituted 2-hydroxy-4-(2-(phenylsulfonamido)acetamido)benzoic acid analogs as inhibitors of STAT protein
#124METHODS AND COMPOSITIONS FOR PREVENTION OF ALLERGIC REACTION
#125Use of small molecule inhibitors targeting the interaction between Rac GTPase and p67 (phox)
#126Methods and compositions for treatment of muscle wasting, muscle weakness, and/or cachexia
#127Bicyclic sulfonamide compounds as sodium channel inhibitors
#128THERAPEUTIC COMPOUNDS AND COMPOSITIONS
#129Precursors of glutamate derivatives
#130COMPOSITIONS AND METHODS FOR JAMM PROTEIN INHIBITION
#131Compound for inhibiting 11β-hydroxy steroid dehydrogenase 1, and a pharmaceutical composition comprising the same
#132BICYCLIC ORGANIC COMPOUNDS SUITABLE FOR THE TREATMENT OF INFLAMMATORY OR ALLERGIC CONDITIONS
#133Bicyclic acetyl-CoA carboxylase inhibitors and uses thereof
#134Pyruvate kinase activators for use in therapy
#135Identification of compounds that disperse TDP-43 inclusions
#136N-(4-(azetidine-1-carbonyl) phenyl)-(hetero-) arylsulfonamide derivatives as pyruvate kinase M2 (PMK2) modulators
#137INHIBITORS OF HISTONE DEACETYLASE AND PRODRUGS THEREOF
#138Substituted aromatic sulfur compounds and methods of their use
#139Quinolinone derivatives
#140Thionating agent
#141Use of compounds for inducing differentiation of mesenchymal stem cells to chondrocytes
#142Heterocyclic compounds as imaging probes of tau pathology
#143Substituted 2-hydroxy-4-(2-(phenylsulfonamido)acetamido)benzoic acid analogs as inhibitors of stat protein
#144Purification tags of synthetic peptides and proteins
#145Thionation process and a thionating agent
#146Biaryl oxyacetic acid compounds
#147QUINOLINE DERIVATIVES AS ANTIBACTERIAL AGENTS
#148QUINOLINE DERIVATIVES AS ANTIBACTERIAL AGENTS
#1493,3-dimethyl tetrahydroquinoline derivatives
#150Affinity ligands and methods for protein purification
#151C-Met Modulators and Method of Use
#152Process for preparing bromo-substituted quinolines
#1533-substituted quinolinium and 7H-indolo[2,3-c]quinolinium salts as new antiinfectives
#154Therapeutic compositions and related methods of use
#155-substituted--phenylethylsulfonamides for the identification of biological and pharmacological activity
#156LIBRARIES OF N-SUBSTITUTED-N-PHENYLETHYLSULFONAMIDES FOR THE IDENTIFICATION OF BIOLOGICAL AND PHARMACOLOGICAL ACTIVITY
#157-GlcNAc transferase inhibitors and uses thereof
#158Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them
#159Anti-inflammatory agents
#160Carboxy isatin hydrazones and their esters as Shp2 inhibitors
#161Bicyclic acetyl-CoA carboxylase inhibitors and uses thereof
#162C-met modulators and method of use
#163Phenoxiacetic acid derivatives
#164Sox-based kinase sensor
#165AROYLQUINOLINE COMPOUNDS
#1663,3-dimethyl tetrahydroquinoline derivatives
#167PHARMACEUTICAL AGENT COMPRISING QUINOLONE COMPOUND
#168ARYL-AND HETARYLSULFONAMIDES AS ACTIVE INGREDIENTS AGAINST ABIOTIC PLANT STRESS
#169Indoline scaffold SHP-2 inhibitors and cancer treatment method
#170Nitrogen-containing aromatic derivatives
#171Bicyclic androgen and progesterone receptor modulator compounds and methods
#172SELECTIVE HYDROXAMIC ACID BASED MMP-12 AND MMP-13 INHIBITORS
#173C-Met Modulators and Method of Use
#174NPY Y5 ANTAGONIST
#175Novel Compounds for Treatment of Cancer and Disorders Associated With Angiogenesis Function
#176Quinoline compound and pharmaceutical composition, preparation method and uses thereof
#177PDE10 inhibitors and related compositions and methods
#178Therapeutic compounds and compositions
#179NPY Y5 antagonist
#180COMPOUNDS WHICH INHIBIT BETA-SECRETASE ACTIVITY AND METHODS OF USE THEREOF
#181Imidate compound and use thereof for pest control
#182Quinoline Derivatives as Antibacterial Agents
#183Nitrogen-containing aromatic derivatives
#184Quinoline Derivatives as Antibacterial Agents
#1852-Substituted and 4-substituted aryl nitrone compounds
#186Bicyclic organic compounds suitable for the treatment of inflammatory or allergic conditions
#187Compounds for the modulation of PPARγ activity
#188Bicyclic androgen and progesterone receptor modulator compounds and methods
#189ANTIBACTERIAL QUINOLINE DERIVATIVES
#190Glucocorticoid Mimetics, Methods of Making Them, Pharmaceutical Compositions, and Uses Thereof
#191TYROSINE DERIVATIVE
#192Methods and Compositions for Modulating Glycosylation
#193New Acetyl Coenzyme A Carboxylase (ACC) Inhibitors And Uses In Treatments Of Obesity And Diabetes Mellitus - 087
#194PDE4B inhibitors and uses therefor
#195CHEMICAL COMPOUNDS
#196Quinolinone farnesyl transferase inhibitors for the treatment of synucleinopathies and other indications
#197Tetrahydroquinolinones and their use as modulators of metabotropic glutamate receptors
#198Quinolinyl and benzothiazolyl modulators
#199Calcium receptor active compounds
#200c-Met modulators and methods of use
#201Quinolines and their therapeutic use
#202Quinoline and quinoxaline derivatives as inhibitors of kinase enzymatic activity
#203Histamine-3 receptor antagonists
#204Compounds and methods for treatment of amyloid-beta-peptide related disorders
#205c-Met modulators and methods of use
#206NOVEL COMPOUNDS FOR TREATMENT OF CANCER AND DISORDERS ASSOCIATED WITH ANGIOGENESIS FUNCTION
#207Novel Sulphonamide Derivatives as Glucocorticoid Receptor Modulators for the Treatment of Inflammatory Diseases
#208Heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-alzheimer agents
#2094-thio substituted quinoline and naphthyridine compounds
#210Sulfonyl-quinoline derivatives
#211Novel 8-Sulfonylamino-3 Aminosubstituted Chroman or Tetrahydronaphtalene Derivatives Modulating the 5Ht6 Receptor
#212Quinoline Compounds Capable of Binding the Cb2 and/or the 5-Ht6 Receptor
#213PDE10 inhibitors and related compositions and methods
#214Phenylalanine derivatives
#2158-(1-Piperazinyl)-Quinoline Derivatives and Their Use in the Treatment of Cns Disorders
#216Arylsulfones and uses related thereto
#217Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof
#218Cyclic and acyclic hydrazine derivatives compositions including them and uses thereof
#219Novel Chemical Process For the Synthesis of Quinoline Compounds
#220SULFONYLTRYPTOPHANOLS
#221Novel Inhibitors of Histone Deacetylase for the Treatment of Disease
#222Inhibitors of histone deacetylase and prodrugs thereof
#223Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them
#224Aryl sulfonamide compounds for treating obesity
#225Asthma and allergic inflammation modulators
#226Sox-based kinase sensor
#227Phenylcarboxylic acid derivatives and use thereof for the treatment of diabetes
#228Histone deacetylase inhibitors
#229Inhibitors of Histone Deacetylase
#230BETA-AMYLOID PROTEIN PRODUCTION/SECRETION INHIBITORS
#231Arylsulfonylnaphthalene derivatives as 5HTantagonists
#232Aryl, heteroaromatic and bicyclic aryl nitrone compounds, prodrugs and pharmaceutical compositions of the same to treat human disorders
#233Piperazine derivatives useful for the treatment of gastrointestinal disorders
#234Sulfonylamino-acetic acid derivatives
#235c-Met modulators and method of use
#236c-Met modulators and method of use
#237N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives
#238Quinoline derivatives and insecticide comprising thereof as active ingredient
#239Substituted quinoline compounds for use as selective estrogen receptor modulator
#2403-((Hetero)arylsulfonyl)-8-'(aminoalkyl)oxyquinolines as 5-ht6 receptor antagonists for the treatment of cns disorders
#241Novel m3 muscarinic acetylcholine receptor antagonists
#242c-Met modulators and methods of use
#243NPY Y5 antagonist
#244Stereospecific enrichment of heterocyclic enantiomers
#245Fluorinated heterocyclic compounds and methods of synthesis
#246Phenoxiacetic acid derivatives
#247Quinoline derivatives as antibacterial agents
#2483-methanesulfonylquinolines as GABAenhancers
#249Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
#250Apparatus for curing a composite laminate
#251Nitrogen-containing aromatic derivatives
#252Novel compounds for treatment of cancer and disorders associated with angiogenesis function
#253Sulfonamide derivatives as PPAR modulators
#254Method for the synthesis of quinoline derivatives
#255Nitrogen-containing aromatic derivatives
#256PARP inhibitors
#257Alpha, alpha-disubstituted benzylglycine derivatives as HIV protease inhibitors
#258Quinoline derivatives as anti-inflammatory agents
#259Substituted quinoline and quinazoline inhibitors of quinone reductase 2
#260PDE4B inhibitors and uses therefor
#261Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease
#262Sulfonylamino-acetic acid derivatives
#263Cannabinoid receptor ligands
#264Substituted sulfonamide compounds useful for the prophylaxis and treatment of conditions relating to obesity, type II diabetes and/or disorders of the central nervous system
#265Tetrahydroquinolones and their use as modulators of metabotropic glutamate receptors
#266Bicyclic androgen and progesterone receptor modulator compounds and methods
#267Tetrahydroquinolones and their use as modulators of metabotropic glutamate receptors
#268Compounds
#269Arylsulfones and uses related thereto
#270Gly1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders
#271Sulphones for inhibition of gamma secretase
#272Dichlorinated heterocyclic compounds and methods of synthesis
#273Beta-secretase inhibitors and methods of use thereof
#274β-amyloid protein production/secretion inhibitor
#275Metabotropic glutamate receptor antagonists
#276Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors
#277Cycloalkyl-substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments
#2782-Substituted and 4-substituted aryl nitrone compounds
#2793-Thia-4-arylquinolin-2-one potassium channel modulators
#280Method for the synthesis of quinoline derivatives
#281Mycobacterial inhibitors
#282Anthranilamides with heteroarylsulfonyl side chain, process of preparation, and use
#283Compounds for the treatment of male erectile dysfunction
#2843-Thia-4-arylquinolin-2-one derivatives as smooth muscle relaxants
#285Androgen receptor antagonists
#2863-thia-4-arylquinolin-2-one derivatives
#287Potassium channel modulators
#288Aryl, heteroaromatic and bicyclic aryl nitrone compounds, prodrugs and pharmaceutical compositions of the same to treat human disorders
#289Fluorinated heterocyclic compounds and methods of synthesis
#290Butyric acid derivatives
#291Pyridinone derivatives for treatment of atherosclerosis
#292Sulfonamide derivatives